David Hartenbaum, MD
Advertisement
Articles by David Hartenbaum, MD
Advertisement
Latest Updated Articles
- Quantitative and Cost Evaluation of Three Antiglaucoma Beta-Blocker Agents: Timoptic-XE7 versus Two Generic Levobunolol Products
Published: February 1st 1996 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL
3
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
4
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
5
